
    
      The patients with right ventricular dysfunction who are diagnosed by CT pulmonary angiography
      will receive 20 mg of single-dose recombinant tissue plasminogen activator delivered through
      the in this study. The Change of RV to LV Diameter Ratio,Rate of death,rate of major
      bleeding,pulmonary embolism recurrence at 1month will be reviewed to assess the efficacy and
      safety.
    
  